Skip to content
10-K

Annual Report

MBX Biosciences, Inc. MBX

0001193125-26-103121

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 6, 2026 47.51M sh
Shares Diluted FY 2025 · Dec 31, 2025 36.51M sh
Shares Diluted FY 2025 · Dec 31, 2024 10.64M sh
Capex FY 2025 · Dec 31, 2025 $1.93M
Capex FY 2025 · Dec 31, 2024 $874K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$79.95M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$54.68M
Cash And Equivalents FY 2025 · Dec 31, 2025 $75.29M
Cash And Equivalents FY 2025 · Dec 31, 2024 $49.35M
Stockholders Equity FY 2025 · Dec 31, 2025 $369.22M
Stockholders Equity FY 2025 · Dec 31, 2024 $257.44M
Stockholders Equity FY 2025 · Dec 31, 2023 −$72.47M
Current Liabilities FY 2025 · Dec 31, 2025 $15.5M
Current Liabilities FY 2025 · Dec 31, 2024 $11.05M
Total Liabilities FY 2025 · Dec 31, 2025 $15.92M
Total Liabilities FY 2025 · Dec 31, 2024 $11.09M
Current Assets FY 2025 · Dec 31, 2025 $381.54M
Current Assets FY 2025 · Dec 31, 2024 $267.29M
Total Assets FY 2025 · Dec 31, 2025 $385.14M
Total Assets FY 2025 · Dec 31, 2024 $268.54M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.38
Eps Diluted FY 2025 · Dec 31, 2024 −$5.82
Eps Basic FY 2025 · Dec 31, 2025 −$2.38
Eps Basic FY 2025 · Dec 31, 2024 −$5.82
Sga Expense FY 2025 · Dec 31, 2025 $18.9M
Sga Expense FY 2025 · Dec 31, 2024 $10.78M
Rd Expense FY 2025 · Dec 31, 2025 $79.16M
Rd Expense FY 2025 · Dec 31, 2024 $57.42M
Net Income FY 2025 · Dec 31, 2025 −$86.97M
Net Income FY 2025 · Dec 31, 2024 −$61.92M
Operating Income FY 2025 · Dec 31, 2025 −$98.06M
Operating Income FY 2025 · Dec 31, 2024 −$68.19M